vs
MVB FINANCIAL CORP（MVBF）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
MVB FINANCIAL CORP的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.0倍（$36.7M vs $35.5M），MVB FINANCIAL CORP净利率更高（0.0% vs -304.2%，领先304.2%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 2.8%）
MVB金融公司是总部位于美国西弗吉尼亚州的金融控股企业，主要提供商业与零售银行服务、财富管理、抵押贷款及存款产品，同时面向金融科技、游戏领域企业提供专项数字银行解决方案，服务覆盖美国中大西洋地区。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
MVBF vs RXRX — 直观对比
营收规模更大
MVBF
是对方的1.0倍
$35.5M
净利率更高
MVBF
高出304.2%
-304.2%
两年增速更快
RXRX
近两年复合增速
2.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $36.7M | $35.5M |
| 净利润 | $0 | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | — | -304.8% |
| 净利率 | 0.0% | -304.2% |
| 营收同比 | — | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | $0.39 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MVBFRXRX
| Q1 26 | $36.7M | — | ||
| Q4 25 | $39.1M | $35.5M | ||
| Q3 25 | $61.2M | $5.2M | ||
| Q2 25 | $33.7M | $19.2M | ||
| Q1 25 | $33.7M | $14.7M | ||
| Q4 24 | $46.2M | $4.5M | ||
| Q3 24 | $33.2M | $26.1M | ||
| Q2 24 | $34.7M | $14.4M |
净利润MVBFRXRX
| Q1 26 | $0 | — | ||
| Q4 25 | $4.2M | $-108.1M | ||
| Q3 25 | $17.1M | $-162.3M | ||
| Q2 25 | $2.0M | $-171.9M | ||
| Q1 25 | $3.6M | $-202.5M | ||
| Q4 24 | $9.4M | $-178.9M | ||
| Q3 24 | $2.1M | $-95.8M | ||
| Q2 24 | $4.1M | $-97.5M |
毛利率MVBFRXRX
| Q1 26 | — | — | ||
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% |
营业利润率MVBFRXRX
| Q1 26 | — | — | ||
| Q4 25 | 13.9% | -304.8% | ||
| Q3 25 | 38.3% | -3327.6% | ||
| Q2 25 | 9.4% | -916.8% | ||
| Q1 25 | 14.3% | -1297.9% | ||
| Q4 24 | 26.5% | -4042.4% | ||
| Q3 24 | 8.4% | -377.1% | ||
| Q2 24 | 15.9% | -697.4% |
净利率MVBFRXRX
| Q1 26 | 0.0% | — | ||
| Q4 25 | 10.8% | -304.2% | ||
| Q3 25 | 28.0% | -3135.3% | ||
| Q2 25 | 5.9% | -894.2% | ||
| Q1 25 | 10.6% | -1373.3% | ||
| Q4 24 | 20.4% | -3935.5% | ||
| Q3 24 | 6.3% | -367.5% | ||
| Q2 24 | 11.8% | -676.6% |
每股收益（稀释后）MVBFRXRX
| Q1 26 | $0.39 | — | ||
| Q4 25 | $0.32 | $-0.17 | ||
| Q3 25 | $1.32 | $-0.36 | ||
| Q2 25 | $0.15 | $-0.41 | ||
| Q1 25 | $0.27 | $-0.50 | ||
| Q4 24 | $0.72 | $-0.56 | ||
| Q3 24 | $0.16 | $-0.34 | ||
| Q2 24 | $0.31 | $-0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $177.6M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $334.9M | $1.1B |
| 总资产 | $3.3B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资MVBFRXRX
| Q1 26 | $177.6M | — | ||
| Q4 25 | $244.1M | $743.3M | ||
| Q3 25 | $300.0M | $659.8M | ||
| Q2 25 | $399.4M | $525.1M | ||
| Q1 25 | $251.4M | $500.5M | ||
| Q4 24 | $317.9M | $594.4M | ||
| Q3 24 | $610.9M | $427.6M | ||
| Q2 24 | $455.5M | $474.3M |
总债务MVBFRXRX
| Q1 26 | — | — | ||
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M |
股东权益MVBFRXRX
| Q1 26 | $334.9M | — | ||
| Q4 25 | $334.0M | $1.1B | ||
| Q3 25 | $327.8M | $1.0B | ||
| Q2 25 | $302.3M | $919.1M | ||
| Q1 25 | $310.1M | $933.9M | ||
| Q4 24 | $305.7M | $1.0B | ||
| Q3 24 | $303.1M | $524.6M | ||
| Q2 24 | $296.6M | $584.4M |
总资产MVBFRXRX
| Q1 26 | $3.3B | — | ||
| Q4 25 | $3.3B | $1.5B | ||
| Q3 25 | $3.2B | $1.4B | ||
| Q2 25 | $3.2B | $1.3B | ||
| Q1 25 | $3.0B | $1.3B | ||
| Q4 24 | $3.1B | $1.4B | ||
| Q3 24 | $3.4B | $726.5M | ||
| Q2 24 | $3.3B | $775.9M |
负债/权益比MVBFRXRX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流MVBFRXRX
| Q1 26 | — | — | ||
| Q4 25 | $4.0M | $-46.1M | ||
| Q3 25 | $-2.6M | $-117.4M | ||
| Q2 25 | $7.4M | $-76.4M | ||
| Q1 25 | $14.1M | $-132.0M | ||
| Q4 24 | $-285.0K | $-115.4M | ||
| Q3 24 | $8.6M | $-59.2M | ||
| Q2 24 | $26.9M | $-82.2M |
自由现金流MVBFRXRX
| Q1 26 | — | — | ||
| Q4 25 | $2.1M | $-47.3M | ||
| Q3 25 | $-3.5M | $-117.6M | ||
| Q2 25 | $7.2M | $-79.6M | ||
| Q1 25 | $13.9M | $-133.8M | ||
| Q4 24 | $-1.9M | $-116.7M | ||
| Q3 24 | $8.3M | $-63.8M | ||
| Q2 24 | $26.6M | $-83.4M |
自由现金流率MVBFRXRX
| Q1 26 | — | — | ||
| Q4 25 | 5.4% | -133.1% | ||
| Q3 25 | -5.8% | -2272.5% | ||
| Q2 25 | 21.5% | -413.9% | ||
| Q1 25 | 41.2% | -907.4% | ||
| Q4 24 | -4.1% | -2567.7% | ||
| Q3 24 | 25.1% | -244.6% | ||
| Q2 24 | 76.7% | -578.5% |
资本支出强度MVBFRXRX
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | 3.5% | ||
| Q3 25 | 1.6% | 4.7% | ||
| Q2 25 | 0.6% | 16.4% | ||
| Q1 25 | 0.8% | 12.4% | ||
| Q4 24 | 3.5% | 28.6% | ||
| Q3 24 | 0.9% | 17.5% | ||
| Q2 24 | 0.7% | 8.2% |
现金转化率MVBFRXRX
| Q1 26 | — | — | ||
| Q4 25 | 0.95× | — | ||
| Q3 25 | -0.15× | — | ||
| Q2 25 | 3.72× | — | ||
| Q1 25 | 3.95× | — | ||
| Q4 24 | -0.03× | — | ||
| Q3 24 | 4.15× | — | ||
| Q2 24 | 6.57× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MVBF
| Net Interest Income | $28.5M | 78% |
| Noninterest Income | $8.2M | 22% |
RXRX
暂无分部数据
